Mangalam Drugs & Organics

80.18
+0.98
(1.24%)
Market Cap
126.91 Cr
EPS
-5.73
PE Ratio
12.28
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
144.99
52 Week Low
74.05
PB Ratio
0.85
Debt to Equity
0.78
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,770.00
#1 4,24,682.29
34.87
#1 49,887.20
12.06
#1 9,648
13.77
59.55
5,763.00
1,52,989.54
72.74
8,184.00
0.89
1,600
#1 64.53
50.90
1,495.70
1,20,794.97
23.51
26,520.70
14.17
4,155
47.38
55.43
3,247.70
1,09,916.93
58.33
10,785.70
11.59
1,656
13.54
59.71
2,427.70
1,00,161.69
48.93
10,615.60
19.57
1,942
-16.38
56.35
1,151.45
96,083.36
#1 17.86
28,905.40
12.36
5,578
1.69
45.59
2,095.70
95,677.29
31.98
20,141.50
#1 19.94
1,936
38.82
56.82
901.90
90,752.24
19.78
19,831.50
13.82
3,831
29.92
49.00
1,176.35
68,322.60
19.09
29,559.20
17.55
3,169
-10.04
55.70
29,909.30
63,555.17
47.09
6,097.20
10.80
1,201
16.01
48.49
Growth Rate
Revenue Growth
-1.07 %
Net Income Growth
-812.51 %
Cash Flow Change
-2.74 %
ROE
-860.60 %
ROCE
-81.47 %
EBITDA Margin (Avg.)
-32.41 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
97
102
77
80
89
Expenses
90
91
68
71
80
EBITDA
7
12
8
9
9
Operating Profit %
7 %
11 %
11 %
11 %
10 %
Depreciation
4
4
4
4
4
Interest
3
4
4
4
4
Profit Before Tax
0
4
1
1
1
Tax
-1
0
-2
-2
0
Net Profit
1
4
3
3
1
EPS in ₹
0.31
2.23
1.70
1.70
0.81

Balance Sheet

Balance Sheet
2024
Total Assets
334
Fixed Assets
148
Current Assets
176
Capital Work in Progress
8
Investments
0
Other Assets
178
Total Liabilities
334
Current Liabilities
164
Non Current Liabilities
34
Total Equity
136
Reserve & Surplus
120
Share Capital
16

Cash Flow

Cash Flow
2024
Net Cash Flow
-3
Investing Activities
-12
Operating Activities
4
Financing Activities
5

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
50.53 %
50.53 %
50.53 %
50.53 %
50.53 %
50.42 %
50.42 %
50.32 %
50.32 %
50.32 %
50.32 %
50.32 %
50.32 %
50.32 %
50.30 %
50.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.10 %
0.26 %
0.21 %
0.11 %
0.11 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
44.27 %
42.68 %
44.53 %
44.39 %
43.85 %
44.18 %
44.12 %
44.27 %
44.22 %
44.64 %
44.54 %
44.43 %
44.22 %
44.70 %
44.91 %
44.78 %
Others
5.19 %
6.78 %
4.93 %
5.07 %
5.61 %
5.40 %
5.46 %
5.41 %
5.46 %
5.05 %
5.14 %
5.15 %
5.20 %
4.77 %
4.67 %
4.80 %
No of Share Holders
0
20,520
21,827
21,071
20,668
20,084
18,988
18,483
17,943
17,890
17,978
18,610
19,173
19,312
19,508
19,679

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.5 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)5 days ago
Board Meeting Outcome for Outcome Board Meeting Held On 29Th March 2025 For Acceptance Of The Resignation Tendered By Chief Financial Officer Of The Company W.E.F. 31St March 20255 days ago
Closure of Trading Window6 days ago
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 06, 2025
Integrated Filing (Financial)Feb 25, 2025
Integrated Filing (Financial)Feb 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2024Feb 13, 2025
Board Meeting Outcome for Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2024Feb 13, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 13Th February 2025 For Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended 31St December 2024Feb 05, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jan 31, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jan 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 17, 2025
Update On Regulation 30 Read With Schedule II Part A Of SEBI (Listing Obligations And Disclosure Requirements)Regulations 2015Jan 16, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJan 16, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jan 14, 2025
Closure of Trading WindowDec 30, 2024
Appointment of Company Secretary and Compliance OfficerDec 04, 2024
Appointment of Company Secretary and Compliance OfficerDec 04, 2024
Appointment of Company Secretary and Compliance OfficerDec 04, 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011Nov 18, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th September, 2024Nov 14, 2024
Board Meeting Outcome for Board Meeting Held On 14Th November 2024 For Declaration Of Un-Audited Satandalone And Consolidated Financial Results For The Quareter Ended 30Th September, 2024Nov 14, 2024
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended 30Th September, 2024Nov 08, 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Nov 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 17, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Announcement Under Regulation 30(Listing Obligationa And Disclosure Requirement) Regarding The Companies Participation In Cphi Event Held In Milan, ItalyOct 11, 2024
Announcement Under Regulation 30 Of SEBI(LODR) Regulations, 2015 Regarding Judgement Passed For Case No. 8766/06 By Vapi Additional Chief Judicial Magistrate Court, Vapi, District Valsad, GujaratOct 08, 2024
Closure of Trading WindowOct 01, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 28, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 28, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Sep 06, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2024
Reg. 34 (1) Annual Report.Sep 04, 2024
Notice Of 51St Annual General Meeting (AGM) Of The Members Of MANGALAM DRUGS AND ORGANICS LIMITED Is Scheduled To Be Held At 03:00 PM On Thursday, September 26, 2024 Through Video Conferencing VC OR Other Audio Visual Means.Sep 04, 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Aug 27, 2024
Intimation As Per Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For Getting Grant From Medicines For Malaria Venture (MMV) For Research And Development Of Pyronaridine.Aug 26, 2024
Disclosure under Regulation 30A of LODRAug 20, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 13, 2024
Approval Of Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended 30.06.2024Aug 13, 2024
Board Meeting Outcome for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30.06.2024Aug 13, 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Aug 09, 2024
Board Meeting Intimation for Board Meeting To Be Held On 13Th August, 2024 Intimation For Approval Of Quarterly Financial Results Of The Company For The Quarter Ended 30Th June, 2024Aug 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 11, 2024
Appointment of Company Secretary and Compliance OfficerJul 09, 2024

Technical Indicators

RSI(14)
Neutral
43.21
ATR(14)
Volatile
4.98
STOCH(9,6)
Neutral
28.07
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
1.01
ADX(14)
Strong Trend
33.47
UO(9)
Bearish
40.22
ROC(12)
Uptrend And Accelerating
6.03
WillR(14)
Neutral
-45.70